52649

🔬 CPT 52649 — Laser Enucleation of Prostate With Morcellation

Quick Reference

wRVU: 12.68 | Global Period: 090 (90 days) | Assistant Payable: ❌ No | Bilateral Indicator: 0

---

📋 Clinical Description

CPT 52649 describes transurethral laser enucleation of the prostate with morcellation, in which the surgeon uses a laser to dissect the prostatic adenoma lobes intact from the surgical capsule (enucleation), then morcellates the enucleated tissue within the bladder into smaller fragments for irrigation and removal. This is the endoscopic equivalent of open simple prostatectomy and removes more adenoma volume than vaporization. The critical distinction from 52648 is technique and tissue retrieval: enucleation separates the adenoma whole, and morcellation is required because the tissue must be broken down to exit through the resectoscope sheath. This code requires documentation of both enucleation and morcellation; vaporization-only procedures, regardless of laser type, are coded as 52648.¹

Benign prostatic hyperplasia represents non-malignant overgrowth of prostatic glandular and stromal tissue that obstructs the urethra; HoLEP (Holmium laser enucleation of the prostate) is considered by many urologists to be the most durable endoscopic treatment for BPH, with outcomes comparable to open simple prostatectomy and a lower re-treatment rate than TURP. The technique is laser-type agnostic — Holmium, thulium, and diode lasers are all used — and code selection remains 52649 regardless of which laser is employed.

Note: CMS finalized a wRVU of 13.00 for 52649 in the 2026 Final Rule, reduced from the RUC-recommended 14.56; after the 2.5% efficiency adjustment, the effective 2026 wRVU is approximately 12.68.²

This procedure may be performed in the following clinical contexts:

• Large-gland BPH (typically >80-100 cc) not amenable to vaporization — HoLEP has no practical upper limit on prostate size, making 52649 the preferred endoscopic approach for very large prostates where vaporization would require excessive operative time.
• BPH with concurrent urinary retention — Complete adenoma removal provides durable relief and the lowest retreatment rate among transurethral approaches; catheter dependence from retention is a strong indication.
• BPH in anticoagulated patients — Like laser vaporization, the inherent hemostasis of enucleation makes it favorable over TURP in patients on anticoagulants or with coagulopathy.
• Recurrent BPH / prior prostatectomy with residual or regrown adenoma — 52649 is appropriate whether this is the patient’s first or a repeat procedure; there is no first/repeat distinction for laser enucleation codes (unlike 52601 vs. 52630 for electrosurgical TURP).
• BPH as an incidental finding or planned concurrent procedure during inpatient admission — When a patient is admitted for another reason (e.g., urinary retention requiring urgent intervention) and HoLEP is performed, the PCS code for the inpatient record will drive DRG assignment.

---

🔬 Anatomical & Procedural Considerations

Procedural Phase	Technique	Key Coding / Clinical Notes
Enucleation	Laser fiber dissects along the plane between the adenoma and surgical capsule; lobes are pushed into the bladder intact	Documentation must specifically describe enucleation — terms like “lobes were dissected from the capsule,” “en-bloc enucleation,” or “HoLEP” support 52649; vague documentation of “laser treatment” does not
Morcellation	Mechanical tissue morcellator (or in newer techniques, laser morcellation) fragments the enucleated lobes within the bladder into irrigatable pieces	Morcellator use must be documented; if a morcellator was not available and tissue was removed by another means, confirm technique with the surgeon before coding
Hemostasis / Postoperative care	Laser coagulation of bleeding points within the surgical capsule; catheter placement	Control of postoperative bleeding is included; do not separately code hemostasis procedures performed in the same session

Clinical Pearl

52649 requires both enucleation AND morcellation. The operative report must document that (1) the adenoma lobe was separated from the surgical capsule via laser dissection (enucleation) AND (2) the enucleated tissue was morcellated within the bladder for removal. If only laser vaporization is described — even if terms like “ablation” or “Holmium” appear — the correct code is 52648, not 52649. Reading past the laser equipment description to the technique is the single most important step in this code family.

---

✅ Procedure Includes

• Preoperative endoscopic assessment of urethra and bladder
• Cystourethroscopy, urethral calibration, dilation, meatotomy — all bundled
• Internal urethrotomy if performed at the same session — bundled
• Transurethral resection of prostate if performed during the same session — bundled
• Laser enucleation of prostatic adenoma lobes from surgical capsule
• Morcellation of enucleated tissue within the bladder
• Irrigation and removal of morcellated fragments
• Hemostasis with laser coagulation of capsular bleeding points
• Catheter placement at end of procedure
• Any vasectomy performed concurrently — bundled

---

❌ Excludes / Do Not Report Together

Code	Description	Relationship to 52649
52648	Laser vaporization of prostate	Mutually exclusive — vaporization is a different technique; do not report 52648 and 52649 for the same session on the same prostate
52601	TURP, electrosurgical, first	Mutually exclusive — electrosurgical resection vs. laser enucleation; TURP performed as part of 52649 is bundled per the code descriptor
52630	TURP, electrosurgical, repeat	Same mutual exclusivity; TURP component is bundled even when performed at the same session
52450	Transurethral incision of prostate	Not separately reportable at the same session; laser-assisted incision of the prostate is captured under 52450, not 52649
E/M codes (992xx)	Office visit, any level	Separately reportable only when modifier -25 is appended to the E/M code, documenting a significant, separately identifiable E/M service beyond the routine pre-procedure assessment

Bundling Alert — Global Period is 090, Not 000 or 010

The 90-day global period for 52649 includes all routine pre-op (day before), intraoperative, and postoperative care for 90 days. The most common audit finding is billing post-op catheter management, cystoscopy for clot retention, or urethral dilation within the global window without a modifier. Modifier -24 is required for unrelated E/M visits within the global period; modifier -78 for unplanned OR return for complications. For any staged or planned second procedure within the window, modifier -58 applies.

---

🌳 Code Tree — Surgery: Vesical Neck and Prostate

CPT 52400-52700  Surgery: Vesical Neck and Prostate
│
├── 52400-52520  Cystourethroscopy and related endoscopic procedures
│
├── 52600-52649  Prostatectomy / Transurethral Surgical Procedures
│   ├── 52601  TURP, electrosurgical, first procedure  (Global: 090)
│   ├── 52630  TURP, electrosurgical, repeat procedure  (Global: 090)
│   ├── 52647  Laser coagulation of prostate  ← DELETED 2026
│   ├── 52648  Laser vaporization of prostate, complete  (Global: 090)
│   └── ▶▶ 52649 ◀◀  Laser enucleation of prostate with morcellation  ← YOU ARE HERE  (Global: 090)
│
└── 52700  Transurethral drainage of prostatic abscess  (Global: 090)

Documentation Requirements

To support medical necessity and accurate billing of CPT 52649, the operative report should clearly reflect:

• Indication: BPH, LUTS, urinary retention, bladder outlet obstruction, or other medically necessary diagnosis
• Approach: Transurethral, endoscopic
• Laser type and settings: e.g., Holmium:YAG laser, specific wattage/energy settings
• Enucleation confirmed: Documentation that the entire prostatic adenoma (all lobes) was enucleated from the surgical capsule
• Morcellation documented: Explicit mention of morcellator use and tissue evacuation
• Hemostasis confirmed: Control of bleeding during and at the end of the procedure
• Any additional procedures performed: Even if bundled, document them — state they are part of the same operative session
• Catheter placement: Foley catheter placed at end of procedure
• Estimated blood loss
• Specimen disposition: Confirmation that tissue was sent to pathology
• Anesthesia type

Note

⚠️ Missing documentation of morcellation specifically may result in downcoding to 52648 (laser vaporization). The distinction is critical — enucleation + morcellation = 52649; vaporization = 52648.

---

💰 RVU & Reimbursement Profile

Component	Value
Work RVU (wRVU)	12.68 (2026 CMS MPFS; CMS finalized 13.00 per CMS-1832-F, then applied 2.5% efficiency adjustment; verify CMS-1832-F Addendum B for exact value)
Global Period	090 (90 days)
Bilateral Indicator	0 — Not a bilateral procedure
Assistant Surgeon	❌ Not payable
Co-Surgeon	❌ Not applicable
Team Surgery	❌ Not applicable
PC/TC Split	❌ No — procedure code only (Indicator 0)
Modifier -51 Exempt	No
Anesthesia	General or spinal/regional anesthesia standard; separately billed under anesthesia codes

2026 wRVU Note — CMS Dispute with RUC

CMS finalized a wRVU of 13.00 for 52649, rejecting the RUC-recommended 14.56, crosswalking instead to CPT 53500. The AUA opposed this reduction. After the 2.5% efficiency adjustment applied universally to procedural codes in 2026, the effective wRVU is approximately 12.68. Medicare physician payment is approximately $657\ast \ast atthenationalaveragepertheBostonScientific2026ProstateHealthreference(\ast \ast sourcedfromCMS-1832-F\ast \ast ).\ast \ast OPPS/ASC\ast \ast facilitypaymentisapproximately\ast \ast$5,478 / $2,730. Always verify against your MAC’s locality-adjusted fee schedule.

---

🏷️ Modifier Reference

Modifier	Name	When to Apply
-52	Reduced Services	Procedure partially completed (e.g., enucleation completed but morcellation could not be performed); document reason
-53	Discontinued Procedure	Procedure stopped before reaching the enucleation phase due to patient safety concern; document reason thoroughly
-58	Staged or Related Procedure	Planned staged second session within the 90-day global period; must be documented as planned/staged in original operative note
-78	Unplanned Return to OR	Return to OR for complication (bleeding, clot retention) during global period; reduces payment to intraoperative component only
-79	Unrelated Procedure During Postoperative Period	Unrelated surgical procedure performed within the 90-day global window
-24	Unrelated E/M During Postoperative Period	Applied to the E/M code when the patient is seen within the global window for a condition unrelated to the HoLEP
-25	Significant, Separately Identifiable E/M	Applied to the E/M code — not 52649 — for a separately documented decision or problem on the day of the procedure
-51	Multiple Procedures	When 52649 is performed alongside other separately reportable surgical procedures
-59	Distinct Procedural Service	When payers incorrectly bundle 52649 with another distinct service performed at the same session

---

🩺 Common ICD-10-CM Pairings

Benign Prostatic Hyperplasia — Primary Grouping

ICD-10 Code	Description	HCC?	Clinical Notes
N40.1	Benign prostatic hyperplasia with lower urinary tract symptoms	❌ No	Most common pairing — use when any LUTS is explicitly documented; do not assign without provider documentation of symptoms
N40.0	Benign prostatic hyperplasia without lower urinary tract symptoms	❌ No	Use only when BPH is documented without any LUTS; typically applies to prophylactic or protocol-based procedures
R33.8	Other retention of urine	❌ No	When urinary retention is separately documented as the driving clinical problem; may be coded with N40.1
N32.0	Bladder neck obstruction	❌ No	When separately documented in addition to BPH; supports medical necessity if the bladder neck is specifically described as obstructed

Associated / Complicating Conditions

ICD-10 Code	Description	HCC?	Clinical Notes
N39.0	Urinary tract infection, site not specified	❌ No	When pre-op or concurrent UTI is documented and treated
N41.0	Acute prostatitis	❌ No	When concurrent infection of the prostate is documented

Underlying Etiology / Complication Codes

ICD-10 Code	Description	HCC?	Clinical Notes
N99.89	Other postprocedural complications, genitourinary system	❌ No	When patient returns within the global period for a documented complication
N39.42	Incontinence without sensory awareness	❌ No	Post-HoLEP stress or urge incontinence documented as a postoperative complication

Coding Specificity Reminder

As with all BPH codes, the single most common specificity error is assigning N40.0 when LUTS is present in the documentation. Any mention of urinary frequency, urgency, nocturia, weak stream, hesitancy, incomplete emptying, or retention constitutes LUTS and mandates N40.1. Additionally, if the prostate volume was documented (by TRUS or MRI), include this in the clinical context — while there is no ICD-10-CM code for prostate size, it supports medical necessity review and should be documented clearly. ICD-10-CM specificity requirements are not optional.

---

🏥 MS-DRG Considerations (Inpatient)

Inpatient Coding Reminder

CPT 52649 is performed primarily in the outpatient hospital or ASC setting, but inpatient admission is more commonly warranted than for 52648 given the larger prostate volumes and longer operative times typical for HoLEP. When the ICD-10-PCS equivalent code drives the inpatient record, principal diagnosis N40.1 or N40.0 maps to MDC 11 and the DRG 665 / 666 / 667 Prostatectomy triplet. DRG tier is determined by the most significant CC/MCC on the claim. Common CCs in this population include CKD, diabetes, obesity, and atrial fibrillation.

---

🔧 ICD-10-PCS Equivalents (Inpatient Facility Coding)

Note

For inpatient claims, the PCS root operation for laser enucleation varies by the extent of tissue removal. Excision (B) is used when a portion of the prostate (the adenoma) is removed, leaving the capsule — this is the standard mapping for HoLEP, where the surgical capsule remains. Resection (T) would apply only if the entire prostate (capsule and all) is removed, which does not occur in transurethral enucleation. The approach for transurethral access is Via Natural or Artificial Opening Endoscopic (8).

PCS Code	Full Description	Applicable Modality
0VB08ZZ	Excision of Prostate, Via Natural or Artificial Opening Endoscopic	Laser enucleation with morcellation (HoLEP, ThuLEP, DiLEP) — adenoma removed, capsule preserved

PCS Character Analysis — 0VB08ZZ

Position	Character	Value	Definition
1	Section	0	Medical and Surgical
2	Body System	V	Male Reproductive System
3	Root Operation	B	Excision (cutting out or off, without replacement, a portion of a body part)
4	Body Part	0	Prostate
5	Approach	8	Via Natural or Artificial Opening Endoscopic
6	Device	Z	No Device
7	Qualifier	Z	No Qualifier

PCS Root Operation: Excision (B) vs. Destruction (5) for Prostate

• Use Excision (B) when the adenoma is physically removed from the body (as in HoLEP — tissue is enucleated and morcellated out) — maps to 52649
• Use Destruction (5) when the tissue is vaporized in situ and no specimen is removed (as in PVP/GreenLight) — maps to 52648
• The defining question: was any tissue physically removed from the patient’s body? If yes → Excision (B); if the tissue was simply destroyed where it stood → Destruction (5)

---

📝 Coding Examples

---

Example 1 — ASC: Large-Gland BPH, HoLEP with Mechanical Morcellation

Clinical Scenario: A 67-year-old male with BPH and LUTS (IPSS score 22, nocturia x4, incomplete emptying) presents for HoLEP. TRUS prostate volume documented at 130 cc. Urologist performs Holmium laser enucleation of three prostatic lobes, which are pushed into the bladder, then uses a tissue morcellator to fragment and irrigate all adenoma tissue. Operative note states: “Three-lobe en-bloc enucleation completed using the Holmium:YAG laser. Morcellator inserted; all enucleated tissue fragmented and irrigated from the bladder. Excellent hemostasis achieved at the capsule.” Catheter placed and removed on postoperative day 1.

Field	Code	Rationale
CPT	52649	Laser enucleation with morcellation, complete; both enucleation (lobe dissection from capsule) and morcellation explicitly documented
PDx	N40.1	BPH with documented LUTS (IPSS, nocturia, incomplete emptying)
SDx	R33.8	Retention of urine — if separately documented as incomplete emptying significant enough to warrant clinical intervention

Note

If the operative note had stated “laser vaporization of the prostate lobes using the Holmium laser” without documenting enucleation and morcellation, the correct code would be 52648, not 52649. Code selection is driven by technique, not by the word “Holmium.”

---

Example 2 — Outpatient Hospital: BPH with Same-Day E/M, Anticoagulated Patient

Clinical Scenario: A 72-year-old male on apixaban for atrial fibrillation with a 145 cc prostate and catheter-dependent urinary retention presents for outpatient HoLEP. The urologist sees the patient in the office the same day as the procedure to review anticoagulation bridging, confirm informed consent, and address new onset of hematuria that was not the pre-planned focus of the encounter. A separately documented E/M note addresses the new hematuria and anticoagulation adjustments. HoLEP with morcellation is completed without complication.

Field	Code	Rationale
CPT 1	99214-25	Separately identifiable E/M: new hematuria evaluation and anticoagulation risk assessment; -25 on the E/M; documentation supports separate decision-making beyond pre-procedure assessment
CPT 2	52649	HoLEP with morcellation, complete
PDx	N40.1	BPH with LUTS / retention
SDx	I48.19	Other persistent atrial fibrillation — CC; documents anticoagulation indication
SDx	R31.9	Hematuria, unspecified — addressed in the E/M; supports the -25 modifier

Warning

Modifier -25 is applied to the E/M code, never to the surgical procedure. The E/M must document a problem or decision that is separate and distinct from the routine pre-procedure assessment — in this scenario, the new hematuria evaluation meets that standard. A note that says only “patient presents for HoLEP today; reviewed consent” is not sufficient to support a separate E/M.

---

Example 3 — Inpatient: Very Large BPH, CKD, Postoperative Incontinence Query

Clinical Scenario: A 78-year-old male with 200+ cc BPH (TRUS-confirmed), CKD stage 3a, and a history of prior pelvic radiation is admitted inpatient for HoLEP given procedural risk and anticipated length of stay. HoLEP with morcellation is completed on day 1 of admission. On day 3, the patient complains of stress urinary incontinence; the provider documents “post-HoLEP stress incontinence — likely temporary.” Coding team considers whether a CDI query is warranted regarding severity of the complication.

Field	Code	Rationale
CPT 1	52649	HoLEP with morcellation, complete
PDx	N40.1	BPH with LUTS — principal diagnosis driving admission
SDx	N18.31	CKD stage 3a — CC; documents comorbidity impacting care
SDx	N39.3	Stress incontinence (male) — documented complication of the procedure

Note

CDI query opportunity: The provider documented “likely temporary” incontinence — query whether the degree of incontinence warrants classification as a significant complication (which could affect DRG tier). Also confirm CKD staging — “CKD stage 3a” is a CC under MS-DRG grouping v43.0. If the provider documents “CKD stage 3a” it codes to N18.31 (CC); if unspecified stage 3, query for a/b distinction when possible to maximize specificity.

---

⚠️ Common Coding Pitfalls

• Coding 52649 based on “Holmium” in the operative note: The Holmium laser is used for multiple prostate procedures including vaporization (52648), incision (52450), and enucleation (52649). Seeing the word “Holmium” alone does not determine the code. Read the description of what the laser did: was the adenoma enucleated from the capsule and then morcellated? If yes, 52649. Was it vaporized in situ without removal? Then 52648.

• Coding 52649 when morcellation was not performed: 52649’s descriptor explicitly requires both enucleation AND morcellation. If the enucleated tissue was removed by a method other than morcellation (e.g., through a mini-cystotomy incision), or if the morcellator malfunctioned and the procedure was incomplete, the code may require a modifier (-52) or a query to the surgeon to clarify the actual work completed before billing.

• Separately billing the TURP component: The descriptor for 52649 explicitly states that transurethral resection of prostate is included if performed. Any separately submitted 52601 or 52630 alongside 52649 for the same session is an NCCI violation and will be denied or recouped.

• Failing to apply the 90-day global correctly: Like 52648, the 90-day global for 52649 includes routine post-op care. Post-HoLEP patients often have temporary incontinence, urgency, or dysuria requiring follow-up — these visits are bundled within the global if related to the procedure. Only visits addressing an unrelated condition (modifier -24) or a documented complication requiring a separate OR encounter (modifier -78) are separately billable.

• N40.0 when LUTS is present: As in all BPH coding, defaulting to N40.0 (without LUTS) when any urinary symptom is documented in the record is a specificity error. N40.1 is required whenever LUTS is present. This is a query-first situation when the record is ambiguous.

• Missing the 2026 wRVU change for compensation contracts: The finalized 2026 wRVU for 52649 (~12.68 after efficiency adjustment) represents a meaningful reduction from prior years’ values. Practices compensating urologists on a wRVU basis should model the impact of this change, particularly for high-volume HoLEP practitioners.

---

📎 Sources

¹ AMA CPT 2026 Professional Edition · ² CMS 2026 Medicare Physician Fee Schedule Final Rule (CMS-1832-F); American Urological Association Final Rule Summary (November 2025) · ³ CMS RVU26A Relative Value Files (October 2025 release) · ⁴ NCCI Policy Manual Chapter 5, CMS 2026 · ⁵ ICD-10-CM Official Guidelines for Coding and Reporting FY2026 · ⁶ ICD-10-PCS Official Guidelines for Coding and Reporting FY2026 · ⁷ Boston Scientific — 2026 Coding & Payment Quick Reference: Prostate Health (CMS-1832-F Addendum B) · ⁸ AAPC Urology Coding Alert — “Pinpoint Spot-On Coding for Laser Prostate Procedures” (August 2017) · ⁹ AAPC Urology Coding Alert — “52647-52649: Obliterate Laser Prostate Treatment Coding Troubles” (February 2012) · ¹⁰ PYA — “2026 wRVU Changes Are Here: What Organizations Need to Know” (February 2026)